That's essential, because the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and work. In other words, we need to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (biotech stocks jeff brown). Now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're designed to do. This was a breakthrough almost no one saw. However it's going to have profound implications for curing illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be a lot of investment opportunities in this space, too. Moving subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (black sea). That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be amazed if it drew back perhaps significantly before going higher - exponential tech investor. I've been covering bitcoin for a very long time now. Among the first research study reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were mostly educating readers. But that's not the huge concern anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So think of that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. future report. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are a lot of great personal companies on the brink of striking the public markets And I have actually been dealing with a brand-new method for you to invest even prior to these business go public.
This chance has been constructing over the last few years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the details. Go right here to schedule your area for free.
Emma Walsh here, managing editor of the Diary. Routine Journal readers understand that tech isn't our normal beat (last week). And when it concerns tech investing, we leave it to the experts. Thankfully, we have numerous such experts in our Rolodex. Our colleague Jeff Brown will recognize to our long time readers. He is one of the most accomplished tech investing specialists we know (jeff brown tech stock 2021). In reality, he had numerous triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge image and predict what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and much more. These patterns are experiencing exponential growth and creating unbelievable opportunities for financiers. I want to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. angel investor. However in spite of what lots of readers may think, this is a trend that's just getting started. Although the COVID-19 pandemic interrupted supply chains in 2015, a remarkable 250 million 5G-enabled gadgets were still sold.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown market predictions). Losing two months of production and sales really impacts how many 5G devices are offered in the fiscal year. When you think about all of that, offering 250 million units is impressive. More significantly, the hold-ups triggered by the pandemic created a lots of pent-up need. And that need is now going to be pressed into 2021. In truth, I predict that more than 500 million 5G gadgets will be shipped in 2021 - jeff brown top biotech 2020. Which's not my only 5G prediction When I have actually spoken about 5G in the past, I've described its three different stages.
In Phase 2, 5G gadgets go on sale. 5G phones and other items start to reach customers. And in Stage Three, 5G services begin to be offered (what is the legacy report predicting). That's when we start to see applications running on 5G networks. Believe of things like huge multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Stage 3 by this summertime. This begins something of a virtuous cycle: Many people don't really care about the innovation. However they will care if there are interesting applications that can just be accessed with a 5G phone.
That causes more 5G apps being established. In reality, 5G is going to open up a suite of unbelievable applications: self-driving cars, the Web of Things, robotic surgical treatment, and more. All of these innovations need 5G. The investment opportunities moving forward will be huge. Stepping away from 5G, the next essential innovation I foresee in 2021 is CRISPR genetic editing. CRISPR stands for "clustered routinely interspaced brief palindromic repeat." It's a mouthful. However it is among the most exciting developments in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software.
The program can crash or not operate correctly. CRISPR uses a similar concept however with our hereditary code. "Typos" in our genome can cause disease. CRISPR can fix these "typos." For several years, CRISPR was primarily a specific niche innovation that wasn't well comprehended. And throughout that time, there were really only 3 companies operating in this space. But things are changing. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're dealing with illness and seeing that this technology just works. And as a result, a "second crop" of early-stage CRISPR business is going public and delivering incredible returns. This whole market is efficiently a greenfield opportunity.
There's space for lots of companies to exist in this area. last year. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that 2 or three more genetic editing companies will hold their IPOs. Sticking with biotechnology, we are seeing incredible things taking place at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its newest Alpha, Fold software can precisely anticipate the folding of a protein based exclusively on its amino acid series with 92. 4% accuracy. That's important since the way a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has been an experimental process. However now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're created to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one however a number of drug therapies produced utilizing this innovation. This was among those developments that almost nobody saw. However it's going to have profound ramifications for treating disease. And, obviously, there will be lots of financial investment opportunities in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be shocked if it drew back maybe substantially before going greater. I have actually been covering bitcoin for a very long time now. Among the first research study reports I ever published was on bitcoin - brownstone research stock. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for any person who followed my suggestion. But at the time of that initial recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
But nobody is asking that concern anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. diplomatic relations. Mass, Mutual is a 150-year-old organization. So believe about that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the info is up to date since February 2021, but we might not individually verify this claim. Provided Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an exact figure at this moment. Brown is best understood for his sage-like ability to select winning innovation stocks. He spent more than 25 years looking into technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an exceptional point of view on the marketplace. He's constantly on the hunt for brand-new opportunities, and he shares a number of his best picks in the Near Future Report.
That's high praise, however it's not absurdly reasoned. Brown has an exceptional reputation as a stock-picker, and he effectively forecasted some of the biggest economic events of the previous 20 years. Although he doesn't appear to release his picks to the public, the service's success is a direct indication of Brown's stock-picking prowess. Nobody on Wall Street gets it right each time, however Jeff Brown's accurate predictions have earned him legions of devoted followers. That says a lot about his capability. The Near Future Report is published by Brownstone Research study, a prominent financial research study publisher. Brownstone Research study provides numerous research study services with a wide range of specializations - jeff brown stock predictions.
The business is also affiliated with Bonner & Partners, another well-respected research publisher - biotech stock. On its website, Brownstone says its mission is to offer retail financiers with professional-grade research: "For too long, the finest investment research study has not been readily available to individual financiers. It has been typically reserved for investment banks, hedge funds, private equity, and high-net-worth customers. future report review. The objective of Brownstone Research is to make that type of exclusive research offered to any investors wanting to get an edge in the markets. The goal is easy to deliver special and rewarding financial investment research found nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise serves as the company's Chief Investment Analyst.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to use its clients. After years of steady success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a household name throughout most of America. If you know even a little bit about the market, you understand that he has a track record as a King Midas of sorts. diplomatic relations. Everything he touches turns to gold! Jeff is well mindful of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge task.
In truth, Brown believes S.A.V. jeff brown. could be "the most significant trend of the 2020s, and he's not alone. Check out these quotes from other well-known S.A.V. bulls: Elon's next huge act will be marrying two cutting-edge technologies: artificial intelligence and electric cars and trucks. Musk hopes the mix will help him establish the very first fully-autonomous, self-driving vehicles ever. It's absolutely nothing brief of the automobile market's Holy Grail. As you understand, electrical cars and self-driving vehicle stocks have been huge this year, however the Wall Street maker has actually approved buzz without much concrete result. In spite of a drastic increase in competition over the past few years, Brown still thinks Musk has the finest possibility of putting everything together.
tech might be the magic string that ties everything together. S.A.V. means Shared Autonomous Car, and it might be the future of transport. Basically, this technology would allow you to rent your automobile as a self-governing, self-driving taxi when you're not using it. You simply leave the car and press a button on an app that informs the car to "sign up with the fleet." Next thing you understand, you're unwinding on your couch while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a hefty piece of the earnings. It sounds insane, however it could be closed than you think.